Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)
Cooper Companies (COO) recorded quarterly Non-Current Deffered Revenue of $208.8 million in Q2 2026, up 1.16% quarter-over-quarter from $206.4 million in Q1 2026, and up 6.31% year-on-year from $196.4 million in Q2 2025.
Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Cooper Companies has disclosed Non-Current Deffered Revenue across 6 years of filings, most recently posting $208.8 million for Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million; the trailing twelve-month figure through Apr 2026 stood at $208.8 million (up 6.31% YoY), and the FY2025 full-year result was $201.8 million, up 4.4% from the prior year.
- Non-Current Deffered Revenue was $208.8 million for Q2 2026 at Cooper Companies, up from $206.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $208.8 million in Q2 2026 and troughed at $182.6 million in Q2 2023.
- The 5-year median for Non-Current Deffered Revenue is $193.4 million (2025), against an average of $194.1 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue surged 198200.0% in 2022, then declined 7.11% in 2023.
- Year by year, Non-Current Deffered Revenue stood at $198.3 million in 2022, then declined by 7.11% to $184.2 million in 2023, then advanced by 4.94% to $193.3 million in 2024, then rose by 4.4% to $201.8 million in 2025, then gained by 3.47% to $208.8 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $208.8 million in Q2 2026, $206.4 million in Q1 2026, and $201.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 163.15 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 11.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 208.80 Mn |
| Jan 31, 2026 | 206.40 Mn |
| Oct 31, 2025 | 201.80 Mn |
| Jul 31, 2025 | 199.40 Mn |
| Apr 30, 2025 | 196.40 Mn |
| Jan 31, 2025 | 193.40 Mn |
| Oct 31, 2024 | 193.30 Mn |
| Jul 31, 2024 | 190.80 Mn |
| Apr 30, 2024 | 188.60 Mn |
| Jan 31, 2024 | 186.30 Mn |
| Oct 31, 2023 | 184.20 Mn |
| Jul 31, 2023 | 185.50 Mn |
| Apr 30, 2023 | 182.60 Mn |
| Jan 31, 2023 | 195.10 Mn |
| Oct 31, 2022 | 198.30 Mn |
| Oct 31, 2021 | 100,000.00 |